MX9201014A - Lowering blood cholesterol levels using cellulose ethers.

38 members in 21 offices

This recordMember, by publication datePriority claim11 more offices are in the list below

Priority claims
Document	Office	Kind	Date
66639291	United States of America	A	1991-03-08
84017892	United States of America	A	1992-02-24

Family members, oldest first
Document	Office	Kind
MX9201014AThis record	Mexico	A	1992-09-01
CA2062412A1	Canada	A1	1992-09-09
IE920730A1	Ireland	A1	1992-09-09
AU1149392A	Australia	A	1992-09-10
EP0503496A1	European Patent Office (EPO)	A1	1992-09-16
WO9215313A1	World Intellectual Property Organization (WIPO)	A1	1992-09-17
IL101148D0	Israel	D0	1992-11-15
NO933104D0	Norway	D0	1993-08-31
NO933104L	Norway	L	1993-08-31
FI933893A	Finland	A	1993-09-06
FI933893A7	Finland	A7	1993-09-06
FI933893L	Finland	L	1993-09-06
ZA921691B	South Africa	B	1993-11-17
HU9302531D0	Hungary	D0	1993-12-28
HUT65208A	Hungary	A	1994-05-02
JPH06505488A	Japan	A	1994-06-23
EP0503496B1	European Patent Office (EPO)	B1	1995-01-25
AT117555T	Austria	T	1995-02-15
ATE117555T1	Austria	T1	1995-02-15
AU657301B2	Australia	B2	1995-03-09
DE69201255D1	Germany	D1	1995-03-09
DK0503496T3	Denmark	T3	1995-04-10
ES2068623T3	Spain	T3	1995-04-16
DE69201255T2	Germany	T2	1995-07-20
GR3015652T3	Greece	T3	1995-07-31
IE67435B1	Ireland	B1	1996-04-03
US5585366A	United States of America	A	1996-12-17
US5721221A	United States of America	A	1998-02-24
HK1010036A1	Hong Kong, China	A1	1999-06-11
KR100216495B1	Republic of Korea	B1	1999-08-16
NO306284B1	Norway	B1	1999-10-18
UA27782C2	Ukraine	C2	2000-10-16
IL101148A	Israel	A	2001-10-31
CA2062412C	Canada	C	2002-10-15
JP2003155243A	Japan	A	2003-05-27
JP3651894B2	Japan	B2	2005-05-25
JP2007217424A	Japan	A	2007-08-30
JP4116861B2	Japan	B2	2008-07-09

2 legal events, as the office reported them to INPADOC

Point at a mark for the event

Legal events, newest first
	Event	Code
2014-02-28	Annulment or lapse due to non-payment of feesLapsedMM	MM
1997-11-26	Grant or registrationFG	FG

English: PHARMACEUTICAL COMPOSITION TO DECREASE THE CHOLESTEROL LEVEL IN PLASMA.
Spanish: COMPOSICION FARMACEUTICA PARA DISMINUIR EL NIVEL DE COLESTEROL EN PLASMA.

CPC, 4: A23L33/24
Y10S426/804
A61P3/10
A61P3/06
Filled: the office’s first classification
IPC, 5: A23L1 30
A23L1 308
A61K31 715
A61K31 717
A61P3 06

Lowering blood cholesterol levels using cellulose ethers.